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Summary: Cholesterol oxidase, coupled with the catalase and aldehyde dehydrogenase, is proposed for the determi-
nation of cholesterol. The main advantages of this procedure over comparable methods employing cholesterol oxidase
are its short reaction time and the use of NADP which permits the direct calculation of the cholesterol concentration
from the absorbance value.
Neue enzymatische Methode zur Bestimmung der Cholesterinkonzentration. Verwendung von Aldehyddehydrogenase
zur Indikation H2O2-bildender Reaktionen, 2. Mitteilung
Zusammenfassung: Die mit Katalase und Aldehydrbgenase gekoppelte Cholesterinoxidase-Reaktion wird zum Nach-
weis der Cholesterinkonzentration vorgeschlagen. Die wichtigsten Vorteile dieses Verfahrens gegenüber vergleichbaren
Cholesterinoxidase-Methoden sind eine kurze Reaktionszeit und der Einsatz von NADP, der eine direkte Berechnung
der Konzentration aus den Absorptionswerten ermöglicht.
Introduction
Recently we have proposed the use of catalase coupled
with aldehyde dehydrogenase to measure the action of
H2O2 producing oxidoreductases (1,2). Meanwhile this
principle has been extensively evaluated for the deter-
mination of uric acid in human serum and urine samples
(3). The main advantages over comparable methods are:
the reaction is completed in a few minutes and the use
of NAD"1" or NADP* (3) permits the direct calculation
of the substrate concentration from the absorbance value
without reference to a standard solution. This is espe-
cially relevant if the preparation of primary standard
solutions is problematical.
In the following study the cholesterol concentration
was determined with cholesterol oxidase (4) using the
aldehyde dehydrogenase principle:












cholesterol + fatty acid
cholest-4-en-3-one + H202
acetaldehyde + 2 H2O
acetate+ NAD(P)H + H+
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Materials
Most reagents required are listed in table 1. Cholesterol, Moni-
Trol I and II were obtained from Merz & Dade (D-8000 Munich),
Precilip from Boehringer Mannheim (D-6800 Mannheim), Sero-
norm from Molter GmbH (D-6900 Heidelberg) and Hyland
control serum from Travenol GmbH (D-8000 Munich).
Reagents
1. KCl-diphosphate buffer (pH = 8.5): dissolve 3.75 g KCI
(Merck No. 4936) and 22.25 g tetrasodium-diphosphate-10-
hydrate (Merck No. 6591) in approximately 300 g/1 glycerol,
adjust the pH-value to 8.5 with HC1 and add 300 g/1 glycerol
to 1000 ml.
2. 300 g/lglycerol: 300 g glycerol p. a. (87%, Merck No. 4094)
and bidist. H2O to 1000 ml.
3. NAD* orNADP solution (10 g/1): 100 mg NAD* (Boehringer
Mannheim No. 127 329) or 100 mg NADP* (Boehringer Mann-
heim No. 127 353) and bidist. H2 Ο to 10 ml.
4. Reaction mixture (according to tab. 1). All reagents can be
mixed together: 500 ml KCl-diphosphate buffer, 50 ml ethanol,
50 ml NADP solution, 0.5 ml catalase, J50 mg aldehyde dehydro-
genase, 10 ml cholesterolesterase, 1 ml Triton X100 (5 ml chol-
esteroloxidase). The reaction mixture should be prepared
immediately before use; it is stable approximately 6 hours at
4°C. The final concentrations of the reaction mixture are listed
in table 1.
The aldehyde dehydrogenase can also be obtained from Boehrin-
ger Mannheim (D-6800 Mannheim).
Tab. 1. Final concentrations in the assay for the determination
of the cholesterol content of human sera.
Na4P207 · 10 H2O (Merck No. 6591) 45 mmol/1
KCI (Merck No. 4936) 45 mmol/1
NADP (Boehringer Mannheim No. 127 353) 1.35 mmol/1
Glycerol (Merck No. 4094) approx. 2.5 mol/1
Ethanol (Merck No. 972) 1.54 mol/l
Catalase (Boehringer Mannheim No. 106 810) 910 kU/1
Hydrogen Peroxide: Hydrogen Peroxide Oxido-
reductase (EC 1.11.1.6)
Cholesterol oxidase (EC 1.1.3.6) 400 U/l
(Boehringer Mannheim No. 126934)
Cholesterol esterase 40 mg/1
(Boehringer Mannheim No. 161772)
Triton X-100 (Serva No. 37240) 1 ml/1
(Octylphenol-Polyethyleneglycolether)
Aldehyde: NAD(P) oxidoreductase (EC 1.2.1.5) 500 U/l
(Reactivated from Baker's yeast,
Sigma No. A 6758)
pH-value 9.5
Methods
Manual assay procedure: extrapolation method using a recorder
1000 μΐ (2000 Ml)




Mix; record absorbance for 1-2 minutes at 334 or 340 nm (at
room temperature)
Mix; record absorbance after reaction has come to the end and
extrapolate to absorbance value before the addition of cholesterol
oxidase (Αι)
Cholesterol oxidase 10 (20 M!)
Mix and read absorbance difference (A2) immediately.
Calculation: (Aj-A2) - 16.5 (mmol/1)1).
In each series the cholesterol oxidase absorbance (A2) has to be
determined just once. This value can be used for all samples; it
can usually be neglected.
Mechanized procedure (or for manual measurements in series):













Mix; read absprbance AI against A2 after 20 minutes (room
temperature)
Calculation: (Ai-A2) - 16.34 (mmol/1)1)
For the manual procedure instruments from Eppendorf Ger te-
bau GmbH (D^2000 Hambuig) were used: System 5085 with
Phillips recorder. The mechanized procedure was performed
with an Eppendorf endpoint analyzer 5030.
For an intermethod comparison the original procedure ofAbell
et al. (6) was applied and referred to the cholesterol standard
solution from Merz & Dade (D-8000 Munich).
Regression analysis: the parameters a (intercept with the abscissa)
and b (slope of the regression line) were calculated with Deming's




Under the conditions listed in table 1, the reaction is
completed after approximately 5 minutes in a standard
solution, after 8 minutes in a control or patient serum
with a "normal" cholesterol concentration and after
12—14 minutes in sera with an elevated cholesterol con-
tent at room temperature (fig, 1). The endogenous reac-
tion observed in the reaction mixture is independent of
the sample. It must be accounted for either by the extra-
polation or by the blank subtraction procedure.
Precision
The precision data are listed in table 2. They are satis-
factory with respect to the requirements of the College
of American Pathologists (precisionfrom day to day:
coefficient of variation less than 4.9%) and the Guide-
lines of the Medical Society of West Germany for
Statistical Quality Control and Collaborative Surveys
(precision from day to day: coefficient of variation less
than 10%) (8, 9).
Cholesterol oxidase 10 μΐ (20 μι) l) Coefficient of absorbance: 6334,^ = 6.18 · 106 cm2/mol (4).
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Fig. 1. The reaction kinetics of the procedure proposed for the
determination of the cholesterol concentration at room
temperature (21 °C). The reaction was started by adding
cholesterol oxidase as indicated by arrow. (1) human
serum with an elevated and (2) with a normal cholesterol
concentration; (3) cholesterol solution (Merz & Da e, no
cholesterolester present); (4) Precilip (Boehringer Mann-
heim, containing cholesterol ester).
Tab. 2. Precision from day to day of the determination of the
cholesterol concentration in various control sera.





















































*) mean value (mmol/1) with standard deviation, coefficient of
variation and number of contributing values.
Linearity
The linear range for the method described was verified
with solutions of cholesterol for values-up to 20 mmol/1
using an Eppendorf analyzer 5030 (fig. 2). No attempt to
find the limit of linearity by applying higher concentra-
tion was undertaken. These data are not very meaning-
fill, since the esterase reaction is not considered. There-
fore, patients' sera with a relatively high cholesterol con-
tent were diluted and reanalyzed (tab. 3). No significant
deviation from linearity was observed up to a concentra-
tion of 11 mmql/1 total cholesterol. The theoretical
10 20 30
Cholesterol concentration of the standard [mmol/1]
Fig. 2. Relation between cholesterol concentration of standard
solutions (Preciset from Boehringer Mannheim) and the
results found by the method proposed. Each point is a
mean of 2 determinations. Concentrations above 10
mmol/1 were obtained by adding 20 or 50 μΐ (instead of
10 μ\) of the sample to the reaction mixture. In these
cases, the alteration of the end volume was taken into
consideration. Regression analysis: y = 1.01 χ - 0.24,
χ = 15.5, y = 15.4, r = 0.999, n = 5.
Tab. 3. The effect of diluting patients' sera on the cholesterol
concentration determined with the method described.
Serum No. cholesterol (mmol/1)
undiluted diluted



























amount of oxygen dissolved in the final reaction mixture
is sufficient for a serum concentration of 23 mmol/1
cholesterol.
Intermethod comparison
The cholesterol concentration was determined in several
sera randomly selected from hospital patients with the
method proposed above using an endpoint analyzer
5030 arid the manual procedure ofAbell et al. (6). In
recent years many authors have used this method as a
reference procedure for the determination of the
cholesterol concentration in human sera.
The results obtained show a good correlation (fig. 3).
The intercept of the regression line on the abscissa can
be explained as a positive bias inAbeirs method according
to Allain et al. (10). Several authors reported similar
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Fig. 3. Comparison of the cholesterol concentration determined
with the method described (aldehyde dehydrogenase
method) and with that of Abell et al. in various patients'
sera. Regression analysis: χ = 5.42 ± 1.75, y = 4.85 ± 1.50,
η = 64; classical procedure: y = 0.84x + 0.32; Deming's
procedure: y = 0.86x + 0.19; dotted line: y = x.
results when comparing an enzymatic procedure with
that of Abell et al. (4,10,' 11). This effect is caused by
differing reactivities of naturally occurring non-
cholesterol serum sterols. The normal serum content of
these sterols leads to an average 0.5 mmol/1-error (20 mg/
100 ml) in enzymatic procedures using cholesterol oxidase
and an average 1.0 mmol/1 error (38 mg/100 ml) in the
Abell procedure (10,11).
Interferences
In 2 recent studies 52 representative drugs commonly
used were investigated for possible interferences with
another cholesterol oxidase method (13) and with a
procedure which also applies the catalaseraldehyde
dehydrogenase reaction sequence to determine the uric
acid concentration in biological materials (3), In the
latter assay the sample volume is diluted 1- + 10, whereas
the procedure described above uses a 1 + 100 sample
dilution. Therefore, no interference is to be expected
from all 52 drugs studied in 1. c. (3) and (8).
A high absorbance of the sample matrix could limit the
photometric reading at 340 nm or Hg 334 nm. This limit
is not reached by a bilirubin concentration of 680 μτηοΐ/ΐ,
a hemoglobin concentration of 25 g/1 or a triglyceride
concentration of 20 mrnol/1.
As already mentioned several non-cholesterol sterols
react with cholesterol oxidase (4,10,11), and therefore
interfere with all methods employing this enzyme.
Homogentisic acid (above 25 mg/100 ml) or high activities
of alcohol dehydrogenase can disturb the cholesterol de-
termination with the present indicator system. The former
interference can be avoided by lowering the pH-value of
the reaction mixture, the latter one by using NADP as
coenzyme (3). However, these concentrations are not
expected to occur in human sera.
Detection limit
The detection limit determined by a series of 15 chol-
esterol-free samples according to Kaiser (12) was 0.2
mmol/1.
References
1. Haeckel, R. & Heinz, F. (1975), this j. 13, 244
2. Haeckel, R. & Heinz, F. (1975), Clin. Chem. 27, 118.
3. Haeckel, R. (1976), this j. 14,101-107.
4. Richmond, W. (1973), Clin. Chem. 79,1350-1356.
5. Bergmeyer, H. U. (1975), this j. 13, 507-508 and No. 12, IV.
6. Abell, L. L., Levy, B. B., Brodie, B. B. & Kendall, F. E.
(1958), Standard Methods Clin. Chem. 2, 26-33.
7. Wakkers, P. J. M., Hellendoorn, Η. Β. Α., op de Weegh, G J
& Heerspink, W. (1975), Clin. Chim. Acta 64,173-184.
8. Ausf hrungsbestimmungen und Erl uterungen zu den Richt-
linien der Bundes rztekammer und zur Durchf hrung der
statistischen Qualit tskontrolle und von Ringversuchen im
Bereich der Heilkunde. English translation: Dt. Ges. f. Klin.
Chem. e.V. - Mitteilungen (1974), 2, 33-43.
9. Haeckel, R. (1975), Qualit tssicherung im medizinischen
Laboratorium, Deutscher rzteverlag, K ln, 1-237.
10. Allairi, C. C., Poon, L. S., Chen, C. S. G., Richmond, W.
& Fu, P. C. (1974), Clin. Chem. 20, 470-475.
11. Witte, D. L., Barrett, D. A. & Wycoff, D. A. (1974), Clin.
Chem. 20,1282-1286.
12. Kaiser, H. (1965), Z. Analyt. Chem. 209,1^18.
13. St hler, F., M nz, E. & Kattermann, R. (1975), Deut. Med.
Wochenschr. 100, 876-887.
Prof. Dr. R. Haeckel
KarlrWiechert-AUee 9
D-3 OO Hannover 61
J. Clin. Chem. Clin. Biochem. / Vol. 14,1976 / No. 8
